The future of endovascular treatment: Insights from the ESCAPE investigators

ESCAPE Trial Investigators

doi:10.1177/1747493015622962

The future of endovascular treatment: Insights from the ESCAPE investigators

ESCAPE Trial Investigators

University of Calgary
University of Ottawa
Beaumont Hospital
Royal College of Surgeons in Ireland
Medical University of South Carolina
University of Saskatchewan
Colorado Neurological Institute
Erlanger Hospital
Temple University
Samsung Medical Center, Sungkyunkwan university
University of Montreal
University of Toronto Faculty of Medicine
University of Alberta
University of Calgary

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

The ESCAPE trial demonstrated strong morbidity benefit and mortality reduction for endovascular stroke treatment. Following the release of the main results, the ESCAPE trial investigators convened at a 2-day close-out meeting in March 2015 in Banff, Alberta, Canada. Meeting discussions focused on system implications, procedural characteristics, and future directions. We report the proceedings of the meeting, which provide insights from the trialists into the issues of generalizability, treatment limitations, as well as future directions and opportunities in stroke care optimization.

Original language	English
Pages (from-to)	156-163
Number of pages	8
Journal	International Journal of Stroke
Volume	11
Issue number	2
DOIs	https://doi.org/10.1177/1747493015622962
State	Published - 1 Feb 2016
Externally published	Yes

Keywords

Acute stroke therapy
Cerebral infarction
Intervention
Ischemic stroke
Recombinant tissue plasminogen activator
Stenting
Therapy
Thrombolysis

Access to Document

10.1177/1747493015622962

Cite this

@article{6887fd4b55e6447dbd55f04501547cfa,

title = "The future of endovascular treatment: Insights from the ESCAPE investigators",

abstract = "The ESCAPE trial demonstrated strong morbidity benefit and mortality reduction for endovascular stroke treatment. Following the release of the main results, the ESCAPE trial investigators convened at a 2-day close-out meeting in March 2015 in Banff, Alberta, Canada. Meeting discussions focused on system implications, procedural characteristics, and future directions. We report the proceedings of the meeting, which provide insights from the trialists into the issues of generalizability, treatment limitations, as well as future directions and opportunities in stroke care optimization.",

keywords = "Acute stroke therapy, Cerebral infarction, Intervention, Ischemic stroke, Recombinant tissue plasminogen activator, Stenting, Therapy, Thrombolysis",

author = "\{ESCAPE Trial Investigators\} and Evgenia Klourfeld and Charlotte Zerna and Al-Ajlan, \{Fahad S.\} and Noreen Kamal and Privia Randhawa and Yu, \{Amy Y.\} and Dar Dowlatshahi and John Thornton and David Williams and Christine Holmstedt and Michael Kelly and Donald Frei and Blaise Baxter and Guillermo Linares and Bang, \{Oh Young\} and Poppe, \{Alexandre Y.\} and Walter Montanera and Jeremy Rempel and Muneer Eesa and Menon, \{Bijoy K.\} and Demchuk, \{Andrew M.\} and Mayank Goyal and Hill, \{Michael D.\}",

note = "Publisher Copyright: {\textcopyright} 2016 World Stroke Organization.",

year = "2016",

month = feb,

day = "1",

doi = "10.1177/1747493015622962",

language = "Ingl{\'e}s",

volume = "11",

pages = "156--163",

journal = "International Journal of Stroke",

issn = "1747-4930",

publisher = "SAGE Publications Ltd",

number = "2",

}

TY - JOUR

T1 - The future of endovascular treatment

T2 - Insights from the ESCAPE investigators

AU - ESCAPE Trial Investigators

AU - Klourfeld, Evgenia

AU - Zerna, Charlotte

AU - Al-Ajlan, Fahad S.

AU - Kamal, Noreen

AU - Randhawa, Privia

AU - Yu, Amy Y.

AU - Dowlatshahi, Dar

AU - Thornton, John

AU - Williams, David

AU - Holmstedt, Christine

AU - Kelly, Michael

AU - Frei, Donald

AU - Baxter, Blaise

AU - Linares, Guillermo

AU - Bang, Oh Young

AU - Poppe, Alexandre Y.

AU - Montanera, Walter

AU - Rempel, Jeremy

AU - Eesa, Muneer

AU - Menon, Bijoy K.

AU - Demchuk, Andrew M.

AU - Goyal, Mayank

AU - Hill, Michael D.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The ESCAPE trial demonstrated strong morbidity benefit and mortality reduction for endovascular stroke treatment. Following the release of the main results, the ESCAPE trial investigators convened at a 2-day close-out meeting in March 2015 in Banff, Alberta, Canada. Meeting discussions focused on system implications, procedural characteristics, and future directions. We report the proceedings of the meeting, which provide insights from the trialists into the issues of generalizability, treatment limitations, as well as future directions and opportunities in stroke care optimization.

AB - The ESCAPE trial demonstrated strong morbidity benefit and mortality reduction for endovascular stroke treatment. Following the release of the main results, the ESCAPE trial investigators convened at a 2-day close-out meeting in March 2015 in Banff, Alberta, Canada. Meeting discussions focused on system implications, procedural characteristics, and future directions. We report the proceedings of the meeting, which provide insights from the trialists into the issues of generalizability, treatment limitations, as well as future directions and opportunities in stroke care optimization.

KW - Acute stroke therapy

KW - Cerebral infarction

KW - Intervention

KW - Ischemic stroke

KW - Recombinant tissue plasminogen activator

KW - Stenting

KW - Therapy

KW - Thrombolysis

UR - https://www.scopus.com/pages/publications/84955502015

U2 - 10.1177/1747493015622962

DO - 10.1177/1747493015622962

M3 - Artículo de revisión

C2 - 26783306

AN - SCOPUS:84955502015

SN - 1747-4930

VL - 11

SP - 156

EP - 163

JO - International Journal of Stroke

JF - International Journal of Stroke

IS - 2

ER -

The future of endovascular treatment: Insights from the ESCAPE investigators

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this